BRIEF published on 12/17/2024 at 08:05, 4 days 4 hours ago Ondine Biomedical lance un essai clinique de phase 3 aux États-Unis Ondine Biomedical Essai Clinique Approbation De La FDA Innovation Dans Le Domaine De La Santé Photodésinfection Nasale
BRIEF published on 12/17/2024 at 08:05, 4 days 4 hours ago Ondine Biomedical Begins US Phase 3 Clinical Trial FDA Approval Healthcare Innovation Ondine Biomedical Clinical Trial Nasal Photodisinfection
PRESS RELEASE published on 12/17/2024 at 08:00, 4 days 4 hours ago Ondine Commencing US Phase 3 Clinical Trial Ondine Biomedical Inc. announces the start of Phase 3 clinical trial for its nasal photodisinfection technology, Steriwave, with FDA approval. Trial conducted in collaboration with HCA Healthcare Steriwave Ondine Biomedical Phase 3 Trial HCA Healthcare Nasal Photodisinfection
BRIEF published on 10/28/2024 at 08:05, 1 month 24 days ago Ondine Biomedical Advances Steriwave Commercialization Antimicrobial Resistance Ondine Biomedical Steriwave Technology Healthcare-associated Infections Innovation In Healthcare
BRIEF published on 10/28/2024 at 08:05, 1 month 24 days ago Ondine Biomedical fait progresser la commercialisation de Steriwave Ondine Biomedical Technologie Steriwave Résistance Aux Antimicrobiens Innovation Dans Le Domaine De La Santé Infections Associées Aux Soins De Santé
PRESS RELEASE published on 10/28/2024 at 08:00, 1 month 24 days ago Ondine Continues Commercial Growth Ondine Biomedical Inc. provides updates on the commercial roll-out of its Steriwave® nasal decolonization technology, reducing healthcare-associated infections with light-activated treatment Ondine Biomedical Inc. Nasal Decolonization Steriwave Healthcare-associated Infections Antimicrobial Treatments
BRIEF published on 10/23/2024 at 08:05, 1 month 29 days ago Ondine Biomedical Inc. Launches Steriwave Pilot at King's College Hospital Steriwave Healthcare Innovation Ondine Biomedical Antimicrobial Treatment King's College Hospital
BRIEF published on 10/23/2024 at 08:05, 1 month 29 days ago Ondine Biomedical Inc. lance le projet pilote Steriwave au King's College Hospital Steriwave Ondine Biomedical Innovation Dans Le Domaine De La Santé Hôpital King's College Traitement Antimicrobien
PRESS RELEASE published on 10/23/2024 at 08:00, 1 month 29 days ago Ondine Biomedical Inc. Announces King's College Hospital to Run Steriwave Pilot Ondine Biomedical Inc. collaborates with King's College Hospital to pilot Steriwave® light-activated antimicrobial tech for preventing HAIs. Steriwave rapidly eliminates pathogens without resistance Ondine Biomedical Inc. Steriwave Hospital-acquired Infections Antimicrobial Technology King's College Hospital
BRIEF published on 09/30/2024 at 11:10, 2 months 21 days ago Ondine Biomedical annonce une croissance robuste au premier semestre 2024 Croissance Financière Steriwave Ondine Biomedical Essais Cliniques Adoption À L'hôpital
Published on 12/21/2024 at 01:30, 11 hours 22 minutes ago Quantum Biopharma Announces Closing of Second Tranche
Published on 12/21/2024 at 01:30, 11 hours 22 minutes ago iMetal Resources Closes First Tranche of Previously Announced Non-Brokered Private Placement
Published on 12/21/2024 at 00:05, 12 hours 47 minutes ago Chloeta Awarded GSA OASIS+ IDIQ Contract for Intelligence, Federal Civilian and Defense Support Services
Published on 12/20/2024 at 23:30, 13 hours 22 minutes ago Boron One Announces Extension to Early Warrant Exercise Incentive Program
Published on 12/21/2024 at 00:51, 12 hours 1 minute ago Acquisition of PSI Transcom GmbH by CHAPTERS platform Altamount Software GmbH
Published on 12/21/2024 at 00:45, 12 hours 7 minutes ago EQS-Adhoc: PSI sells the Mobility business unit
Published on 12/20/2024 at 19:10, 17 hours 41 minutes ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 12/20/2024 at 18:56, 17 hours 56 minutes ago CPI PROPERTY GROUP – Progress on Key Initiatives
Published on 12/20/2024 at 18:00, 18 hours 52 minutes ago ARYZTA AG Announces New Board Technology Committee
Published on 12/21/2024 at 12:17, 34 minutes ago AXA annonce la signature d’un accord relatif à la vente d'AXA Investment Managers à BNP Paribas
Published on 12/21/2024 at 12:17, 34 minutes ago AXA announces the signing of a share purchase agreement with BNP Paribas relating to the sale of AXA IM
Published on 12/20/2024 at 18:00, 18 hours 52 minutes ago Kapitaalverhoging door uitoefening van inschrijvingsrechten
Published on 12/20/2024 at 18:00, 18 hours 52 minutes ago Capital increase through exercise of subscription rights
Published on 12/20/2024 at 17:55, 18 hours 57 minutes ago Déclaration des transactions sur actions propres réalisées du 16/12/2024 au 20/12/2024
